लोड हो रहा है...

Cushing’s disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?

Whilst literature is expanding on pasireotide use in the management of Cushing’s disease (CD), there is still currently much unknown about long-term and low-dose pasireotide use in CD. We present a 60-year-old female with residual CD after transphenoidal surgery (TSS), being successfully managed wit...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Endocrinol Diabetes Metab Case Rep
मुख्य लेखकों: Wong, Mimi, Malabu, Usman H, Korah, Ipeson, Tan, YongMong
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Bioscientifica Ltd 2021
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923187/
https://ncbi.nlm.nih.gov/pubmed/33865235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-20-0206
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!